Additionally, antibodies targeting late-trophozoite stage antigen glutamic-acid-rich protein (GARP) initiate programmed cell death in vitro and a lack of anti-GARP antibodies has been associated with risk of severe malaria in one study [229]. This evidence concerns the gene CNGB1 and malaria.